A Japan-based pharmaceutical company focused on rare diseases, urology, and specialty therapies, with a growing presence in global orphan drug markets. The firm develops and commercializes treatments including exon-skipping therapies for Duchenne muscular dystrophy, notably viltolarsen (Viltepso), m...
This page tracks all publicly disclosed congressional trades in Nippon Shinyaku Co., Ltd. (NPPNY), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-02-27 | Daniel Goldman | sell | $1K – $15K |